Australians living with a type of Motor Neurone Disease will have access to a new, cheaper treatment to help slow the ...
Australians living with motor neurone disease (MND) will now have cheaper access to treatment through the Pharmaceutical ...
A disease-modifying drug aimed at a rare genetic subtype of motor neurone disease will be subsidised from next month, cutting ...
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-stage clinical biotechnology company focused on developing ...
23h
Sandra Bullock's wake-up call that changed everything during late partner Bryan Randall’s illness
Sandra Bullock reveals her sister's urgent warning forced her to confront the hidden toll of caregiving during partner Bryan ...
Today, PhenoNet, Inc., an advanced clinical-stage biotechnology company developing therapies for neurodegenerative diseases, announced the completion of recruitment and randomization on August 27, ...
Australians living with a rare type of motor neurone disease (MND) who face a $28,600-per-script bill for a new wonder drug ...
Kim Borthwick signed up for Hoy's Tour de 4 ride and set about seeking support from cyclists to draw attention to her condition ...
Enrollment is complete in a Phase 2b trial of PHENOGENE-1A for mild-to-moderate ALS. ALS is a progressive disorder in which motor neurons die, with nervous system inflammation thought to play a role.
An emerging body of evidence has hinted that ALS survival may be influenced by exposure to toxins or pollutants in the environment. Specifically, a handful of prior studies have found that ALS ...
Chris Johnson’s wife, Brittany, was candid on her role as his full-time caregiver after the former All-Pro running back was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results